[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100630018":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":10,"centralContacts":10,"locations":10,"responsibleParty":24,"collaborators":10,"id":28,"slug":29,"hasResults":30,"nctId":31,"briefTitle":32,"officialTitle":33,"acronym":10,"eligibilityCriteria":34,"healthyVolunteers":30,"sex":35,"minAge":10,"maxAge":10,"enrollmentInfo":36,"targetDuration":10,"studyType":39,"phases":10,"briefSummary":40,"conditions":41,"keywords":10,"overallStatus":43,"whyStopped":10,"lastUpdateSubmitDate":44,"lastUpdatePostDateStruct":45,"startDateStruct":48,"completionDateStruct":50,"leadSponsor":52,"locationsCount":10},{"fullName":5,"class":6},"Assiut University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Schistosoma haematobium",null,"Urine filtration technique (10 ml urine) for diagnosis",[13],"Diagnostic Test: Molecular phylogenetic and haplotype analysis",{"label":15,"type":10,"description":16,"interventionNames":17},"Schistosoma mansoni","Direct wet mount and Kato-Katz thick smear technique (stool) for diagnosis",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"DIAGNOSTIC_TEST","Molecular phylogenetic and haplotype analysis","DNA Sequencing and cox1 Gene Analysis of Schistosoma Isolates",[9,15],{"type":25,"investigatorFullName":26,"investigatorTitle":27,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Intesar Heshmat Yousef","Principial investigator","100630018","prevalence-and-molecular-identification-of-human-schistosomiasis-100630018",false,"NCT07482215","Prevalence and Molecular Identification of Human Schistosomiasis","Prevalence and Molecular Identification of Human Schistosomiasis With Assessment of Associated Epidemiological Risk Factors in Assiut Governorate, Egypt","Inclusion Criteria:\n\n* Patients aged ≥ 5 years of both sexes attending Assiut Governorate hospitals during the study period.\n* Patients clinically suspected of having schistosomiasis (urinary and\u002For intestinal) or referred for parasitological examination.\n* Individuals (or guardians, in case of minors) who provide written informed consent.\n* Patients willing to provide the required biological samples (urine and\u002For stool).\n\nExclusion Criteria:\n\n* Patients Received praziquantel within the last 3 months before sample collection\n* Patients with incomplete clinical or epidemiological data.\n* Patients refusing participation or sample collection.\n* Improperly collected, contaminated, or insufficient samples.\n* Patients suffering from severe comorbid conditions that may interfere with the interpretation of results (e.g., advanced hepatic or renal failure).\n* children with congenital urinary or intestinal anomalies.","ALL",{"count":37,"type":38},359,"ESTIMATED","OBSERVATIONAL","Schistosomiasis remains one of the most important parasitic diseases of public health concern, particularly in developing countries including Egypt. It is caused by a trematode worm (blood flukes) of the genus Schistosoma",[42],"Schistosomiasis","NOT_YET_RECRUITING","2026-03-16",{"date":46,"type":47},"2026-03-19","ACTUAL",{"date":49,"type":38},"2026-05",{"date":51,"type":38},"2027-12",{"name":5,"class":6}]